期刊文献+

应用原生质体融合技术定向改造林可霉素产生菌的探索 被引量:8

Utilization of the Protoplast Fusion Technique to Alter Lincomycin Producing Microorganism
在线阅读 下载PDF
导出
摘要 金色链霉菌Streptomyces aureofaciens(LM^r,CTC^r,产金霉素)的原生质体经U.V.照射40min灭活后,与林可链霉菌林可变种Streptomyces lincolnensis var lincolnensis(LM^r,CTC^s,产林可霉素),在42%PEG(MW6000)诱导下进行种间原生质体融合,在含金霉素50μg/ml的再生平板上直接选择融合子,融合率达9.05×10^(-5)。从大量融合体中筛选到4株产生抗菌物质不同于亲株并较稳定的菌株。对其中一株所产的抗生素作了初步鉴别,推测其结构与林可霉素相近。另一株的薄层层析R_f^(?)值与氯林可霉素相近,尽管此等产物还有待于进一步鉴别,但这一育种途径值得探讨。 The results of interspecific recombination through protoplast fusion between S.lincolnensis var lincolnensis No. 36(LM^(?),CTC^(?)) producing lincomycin and S.aureofaciens (LM^(?), CTC^(?)) producing chlorotetracycline were reported. A heavy dose of U V radiation was used to inactivate the protoplasts of the S.aureofaciens. The UV inactivated protoplasts were fused with the viable protoplasts of S.lincolnensis var lincolnensis No.36. The frequency of protoplast fusion was 9.05×10^(-5) (with PEG 6000).The fermentation product of fusant No.2 show new chromatographic spot similar to that of clindamycin. A new antibiotic substance produced by recombinan No. 3. which is different from lincomycin and chlorotetracycline is obtained. The product of recombinant No.3. with antimicrobial activity show a peak at 210 nm wave length; It suggests that its basic structure might be smilar to that of lincomycin.
机构地区 华东化工学院
出处 《生物工程学报》 CAS CSCD 北大核心 1992年第3期237-242,共6页 Chinese Journal of Biotechnology
基金 国家自然科学基金
关键词 原生质体融合 链霉菌 林可霉素 Streptomyces protoplast fusion recombinant
  • 相关文献

参考文献4

二级参考文献1

  • 1曹文伟,刘金屏,张楚佳,刘桂香,孔玉玲.红霉素链霉菌无活性突变株原生质体融合的研究[J]微生物学杂志,1986(02).

同被引文献72

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部